Weighted Average Number of Shares Outstanding, Basic of BriaCell Therapeutics Corp. from 31 Jul 2021 to 31 Jan 2026

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
BriaCell Therapeutics Corp. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Jul 2021 to 31 Jan 2026.
  • BriaCell Therapeutics Corp. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Jan 2026 was 2,802,337, a 938% increase year-over-year.
  • BriaCell Therapeutics Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 423,114, a 286% increase from 2024.
  • BriaCell Therapeutics Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 109,699, a 99% decline from 2023.
  • BriaCell Therapeutics Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 15,619,676, a 0.81% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

BriaCell Therapeutics Corp. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 2,802,337 +2,532,380 +938% 01 Nov 2025 31 Jan 2026 10-Q 10 Mar 2026 2026 Q2
Q3 2025 1,883,906 +1,706,300 +961% 01 Aug 2025 31 Oct 2025 10-Q 11 Dec 2025 2026 Q1
Q2 2025 423,114 +313,415 +286% 01 May 2025 31 Jul 2025 10-K 16 Oct 2025 2025 FY
Q1 2025 3,735,517 +2,670,069 +251% 01 Feb 2025 30 Apr 2025 10-Q 16 Jun 2025 2025 Q3
Q4 2024 269,957 -795,491 -75% 01 Nov 2024 31 Jan 2025 10-Q 10 Mar 2026 2026 Q2
Q3 2024 177,606 -15,804,120 -99% 01 Aug 2024 31 Oct 2024 10-Q 11 Dec 2025 2026 Q1
Q2 2024 109,699 -15,509,977 -99% 01 May 2024 31 Jul 2024 10-K 16 Oct 2025 2025 FY
Q1 2024 1,065,448 -14,452,624 -93% 01 Feb 2024 30 Apr 2024 10-Q 16 Jun 2025 2025 Q3
Q4 2023 1,065,448 -14,452,570 -93% 01 Nov 2023 31 Jan 2024 10-Q 12 Mar 2025 2025 Q2
Q3 2023 15,981,726 +463,708 +3% 01 Aug 2023 31 Oct 2023 10-Q 16 Dec 2024 2025 Q1
Q2 2023 15,619,676 +125,585 +0.81% 01 May 2023 31 Jul 2023 10-K 29 Oct 2024 2024 FY
Q1 2023 15,518,072 +159,125 +1% 01 Feb 2023 30 Apr 2023 10-Q 14 Jun 2024 2024 Q3
Q4 2022 15,518,018 -270,809 -1.7% 01 Nov 2022 31 Jan 2023 10-Q 18 Mar 2024 2024 Q2
Q3 2022 15,518,018 +279,372 +1.8% 01 Aug 2022 31 Oct 2022 10-Q 14 Dec 2023 2024 Q1
Q2 2022 15,494,091 01 May 2022 31 Jul 2022 10-K 25 Oct 2023 2023 FY
Q1 2022 15,358,947 01 Feb 2022 30 Apr 2022 10-Q 14 Jun 2023 2023 Q3
Q4 2021 15,788,827 01 Nov 2021 31 Jan 2022 10-Q 16 Mar 2023 2023 Q2
Q3 2021 15,238,646 01 Aug 2021 31 Oct 2021 10-Q 14 Dec 2022 2023 Q1

BriaCell Therapeutics Corp. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 423,114 +313,415 +286% 01 Aug 2024 31 Jul 2025 10-K 16 Oct 2025 2025 FY
2024 109,699 -15,509,977 -99% 01 Aug 2023 31 Jul 2024 10-K 16 Oct 2025 2025 FY
2023 15,619,676 +125,585 +0.81% 01 Aug 2022 31 Jul 2023 10-K 29 Oct 2024 2024 FY
2022 15,494,091 +10,974,512 +243% 01 Aug 2021 31 Jul 2022 10-K 25 Oct 2023 2023 FY
2021 4,519,579 01 Aug 2020 31 Jul 2021 10-K 28 Oct 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.